CCI Approves Fortis Healthcare Limited's Acquisition of Additional 31.52% Stake in Agilus Diagnostics Limited. Banking & Finance | Dated: 09 Nov 2024 On 29th October 2024, the Competition Commission of India (CCI) approved the proposal of Fortis Healthcare Limited (FHL), a multi-specialty hospital chain in India, to acquire an additional 31.52% stake in Agilus Diagnostics Limited (Agilus). 🎯 Key Highlights: - Following the transaction, FHL’s shareholding in Agilus will increase from the current 57.68% to 89.2%. 💡 Other Important Facts: (i) CCI also approved the proposed combination which involves the merger of Diligent Power Private Limited (DPPL) into DB Power Limited (DBPL), a wholly-owned subsidiary of DPPL, and the reorganization of Decore Thermal Power Private Limited (DTPPL) through the buyback of certain securities. (ii) CCI approved the proposed combination involving the acquisition of additional stake in ThoughtWorks Holding, Inc. by London-based Apax Partners Limited Liability Partnership (AP Funds) and Temasek Holdings (Private) Limited (Temasek). 📚 Test Your Knowledge: How much additional stake did Fortis Healthcare Limited acquire in Agilus Diagnostics Limited? Correct Answer: 31.52% 🚀 Quick Recap: About CCI Chairman : Ravneet Kaur Headquarters : New Delhi